E-Fund
VC Fund
Vancouver, Canada
E-Fund is a VC fund in Vancouver focused on Health Care and Medical. The E-Fund (VANTEC Entrepreneurs Fund VCC Inc.) was established in 2011 to invest in promising new ventures in British Columbia in a wide range of industry sectors. They are focused on co-investing with other angel investors and early-stage venture capital firms in seed-stage companies with high growth opportunities.The E-Fund involvesspecific investors in the investment due diligence process depending on their industry experience and knowledge and their particular technical expertise. It is their goal to become the ‘Go-to Braintrust’ for active and in-depth angel investing.
- Total investments:
- 62
- Last investment:
- Lead investor:
- 5%
Last updated:
For AI agents: llms.txt
Industries E-Fund invests in
Stages E-Fund invests in
Countries E-Fund invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $474k–$4.2M
- Pre-Seed
- $279k–$1M
- Venture - Series Unknown
- $913k–$43M
Investment Focus
Industry
- Health Care 19 (31%)
- Medical 9 (15%)
- Medical Device 9 (15%)
- Software 7 (11%)
- Biotechnology 6 (10%)
Stage
- Seed 32 (52%)
- Pre-Seed 5 (8%)
- Venture - Series Unknown 3 (5%)
- Series B 2 (3%)
- Series F 2 (3%)
Country
- Canada 35 (56%)
- China 6 (10%)
- United States 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Pieter Dorsman
Chief Financial Officer, Director & Board Member
|
Chief Financial Officer, Director & Board Member | Total investments: 0 | Find email | |
Thealzel Lee
Founder, Director and President
|
Founder, Director and President | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| ViewsML leverages artificial intelligence to enhance virtual diagnostics and precision medicine. The company focuses on transforming spatial biology and translational research by utilizing virtual biomarkers. Their technology aims to improve patient outcomes by providing deeper insights into healthcare diagnostics. ViewsML is involved in developingimmunohistochemistry technology to streamline the diagnostic process and support research objectives efficiently. | $4.9M / Seed / Apr 20, 2026 | ||
| Qase is a B2B SaaS platform that reinvents how law firms and legal organizations manage legal referrals. | $785K / Pre-Seed / Jun 30, 2024 | ||
| VoxCell is creating an extraordinary line of Truly Biomimetic solutions for the drug development industry and the field of Oncology research by creating vascularized cancer tissue models. | $1.1M / Seed / Aug 11, 2022 | ||
| Care2Talk is a video technology platform that provides the easiest and most secure product for older adults in Memory Care, SNF, AL, IL to connect their loved ones & provider groups.Care2Talk is an iOS/Android App which uses a specially designed interface on mobile or tablet device to create an easy-to-use video chat tool for those withcognitive impairments or other limitations. This includes conditions associated with:• Aging & Dementia • Cognitive and Developmental Disabilities • Brain Injuries • Vision and Hearing Impairments (CC) • Physical Disabilities & Mobility Restrictions | $1M / Seed / Jun 12, 2022 | ||
| Frontly's no-code internal admin tooling platform empowers businesses to build custom applications to solve their greatest business challenges in minutes without writing a line of code. | $279.2K / Pre-Seed / Jun 07, 2022 | ||
| Care2Talk is a video technology platform that provides the easiest and most secure product for older adults in Memory Care, SNF, AL, IL to connect their loved ones & provider groups.Care2Talk is an iOS/Android App which uses a specially designed interface on mobile or tablet device to create an easy-to-use video chat tool for those withcognitive impairments or other limitations. This includes conditions associated with:• Aging & Dementia • Cognitive and Developmental Disabilities • Brain Injuries • Vision and Hearing Impairments (CC) • Physical Disabilities & Mobility Restrictions | $1M / Pre-Seed / Feb 12, 2022 | ||
| Lucent BioSciences is a Vancouver-based AgTech start-up driven by accelerating the transition of agriculture to sustainability. Lucent Bio has developed a novel patent-pending fertilizer for agriculture called "Soileos'' using cellulose fibre as a delivery agent. The product improves yield and soil health, and is climate positive,non-polluting, and sustainable. | $4.2M / Seed / Nov 23, 2021 | ||
| Berry Oncology develops medical technology intended to improve cancer prevention and tumor diagnosis. It offers genetic diagnosis solutions from early diagnosis to mid-late monitoring that can solve clinical problems in the direction of several malignant tumors, providing patients with a higher quality of life and reduced risk of cancer.Thecompany's mission is early diagnosis and early treatment of all tumors, all patients receive precise treatment. Along with its vision to become a global icon in the field of early screening and early diagnosis of tumors and a leader in China's tumor gene testing market. | $99.2M / Series B / Aug 05, 2021 | ||
| Miaoshou Doctor is a healthcare service platform for building an online communication service platform between patients and doctors.It helps healthcare professionals and patients to manage post-diagnosis outcomes and allows doctors to actively follow up with their patient's health through additional counseling and prescriptions.Tao He andDaoliang Han founded the company in 2015 and is based in Beijing, Beijing. | $232M / Series F / Aug 04, 2021 | ||
Yuanxin Huibao
|
Yuanxin Huibao is a health insurance technology service provider. It provides insurance for health care in major areas such as major diseases and chronic diseases. It provides users with more reliable medical and medical services and is more insurance. The company offers solutions such as “product actuarial pricing, risk control, user acquisitionand viscosity”. | $231.8M / Series F / Aug 03, 2021 | |
| See all 62 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does E-Fund invest in?
E-Fund invests primarily in Health Care, Medical and Medical Device startups, most often at Seed and Pre-Seed stage. Most of the 62 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is E-Fund's check size?
E-Fund typically joins rounds of $474k–$4.2M at Seed, $279k–$1M at Pre-Seed and $913k–$43M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds E-Fund participates in.
How do I contact E-Fund?
Public channels for E-Fund include X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at E-Fund?
The team at E-Fund includes Pieter Dorsman (Chief Financial Officer, Director & Board Member) and Thealzel Lee (Founder, Director and President). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
